Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter StudyOliver Schröder, Jürgen M. Stein, O Mickisch et al.|The American Journal of Gastroenterology|2005Cited by 234
Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapyWilliam J. Sandborn, Brian G. Feagan, P. Rutgeerts et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 186
Anemia and iron deficiency in gastrointestinal and liver conditionsJürgen M. Stein, Lisandro Pereyra|World Journal of Gastroenterology|2016Cited by 151
OP010 Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 yearsWilliam J. Sandborn, Brian G. Feagan, Stephen B. Hanauer et al.|Journal of Crohn s and Colitis|2017Cited by 13
LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN’S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH 2 YEARSWilliam J. Sandborn, Bruno Silva, P. Rutgeerts et al.|Arquivos Brasileiros de Cirurgia Digestiva Express|2017Cited by 6